JP2021523702A5 - - Google Patents

Info

Publication number
JP2021523702A5
JP2021523702A5 JP2020561751A JP2020561751A JP2021523702A5 JP 2021523702 A5 JP2021523702 A5 JP 2021523702A5 JP 2020561751 A JP2020561751 A JP 2020561751A JP 2020561751 A JP2020561751 A JP 2020561751A JP 2021523702 A5 JP2021523702 A5 JP 2021523702A5
Authority
JP
Japan
Prior art keywords
epitope
seq
aavx
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020561751A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523702A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/030955 external-priority patent/WO2019213668A1/en
Publication of JP2021523702A publication Critical patent/JP2021523702A/ja
Publication of JP2021523702A5 publication Critical patent/JP2021523702A5/ja
Priority to JP2024079802A priority Critical patent/JP2024119818A/ja
Pending legal-status Critical Current

Links

JP2020561751A 2018-05-04 2019-05-06 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ Pending JP2021523702A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024079802A JP2024119818A (ja) 2018-05-04 2024-05-15 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862667360P 2018-05-04 2018-05-04
US62/667,360 2018-05-04
PCT/US2019/030955 WO2019213668A1 (en) 2018-05-04 2019-05-06 Human anti-aav2 capsid polyclonal antibody epitopes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024079802A Division JP2024119818A (ja) 2018-05-04 2024-05-15 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ

Publications (2)

Publication Number Publication Date
JP2021523702A JP2021523702A (ja) 2021-09-09
JP2021523702A5 true JP2021523702A5 (https=) 2022-05-16

Family

ID=68386753

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020561751A Pending JP2021523702A (ja) 2018-05-04 2019-05-06 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ
JP2024079802A Pending JP2024119818A (ja) 2018-05-04 2024-05-15 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024079802A Pending JP2024119818A (ja) 2018-05-04 2024-05-15 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ

Country Status (5)

Country Link
US (1) US20210292370A1 (https=)
EP (1) EP3799568A4 (https=)
JP (2) JP2021523702A (https=)
CN (1) CN112351787A (https=)
WO (1) WO2019213668A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113166208B (zh) 2018-10-02 2024-11-22 沃雅戈治疗公司 重新定向aav衣壳的嗜性
IL293658A (en) * 2019-12-10 2022-08-01 Homology Medicines Inc Adeno-associated virus preparations and a method of using them
JP2023524577A (ja) * 2020-05-05 2023-06-12 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル 改変アデノ随伴ウイルス５カプシドおよびその使用
TWI900553B (zh) 2020-05-13 2025-10-11 美商航海家醫療公司 Aav蛋白殼之趨性重定向
CN113583112B (zh) * 2021-07-30 2022-07-19 上海勉亦生物科技有限公司 Aav特异性抗体及其应用
CN113999861B (zh) * 2021-09-08 2024-03-15 三峡大学 腺相关病毒衣壳蛋白保守区多克隆抗体的制备方法及应用
EP4426716A1 (en) 2021-11-02 2024-09-11 Voyager Therapeutics, Inc. Aav capsid variants and uses thereof
CN114685651B (zh) * 2022-04-15 2023-07-11 三峡大学 一种特异识别aav9衣壳蛋白的多克隆抗体及制备方法
WO2025100417A1 (ja) * 2023-11-06 2025-05-15 株式会社ダイセル Ａａｖのフルカプシドに対するアフィニティポリペプチド

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7749492B2 (en) * 2001-01-05 2010-07-06 Nationwide Children's Hospital, Inc. AAV vectors and methods
JP5136766B2 (ja) * 2004-12-15 2013-02-06 ユニバーシティ オブ ノース カロライナ アット チャペル ヒル キメラベクター
US9725485B2 (en) * 2012-05-15 2017-08-08 University Of Florida Research Foundation, Inc. AAV vectors with high transduction efficiency and uses thereof for gene therapy
TR201908020T4 (tr) * 2011-02-17 2019-06-21 Univ Pennsylvania Doku özgüllüğünü değiştirmek ve aav9-aracılı gen transferini geliştirmek için bileşimler ve yöntemler.
EP2660325A3 (en) * 2012-05-02 2014-02-12 Christian Medical College AAV vectors and corresponding nucleotide sequences and methods
EP3003391B1 (en) * 2013-05-31 2021-09-22 The Regents of The University of California Adeno-associated virus variants and methods of use thereof
WO2015164757A1 (en) * 2014-04-25 2015-10-29 Oregon Health & Science University Methods of viral neutralizing antibody epitope mapping
ES2865487T3 (es) * 2015-09-28 2021-10-15 Univ North Carolina Chapel Hill Métodos y composiciones para vectores virales que evaden los anticuerpos
US11364308B2 (en) * 2016-05-13 2022-06-21 4D Molecular Therapeutics Inc. Adeno-associated virus variant capsids and methods of use thereof
MX2020003888A (es) * 2017-10-18 2020-11-06 Regenxbio Inc Anticuerpos terapeuticos postraduccionalmente modificados completamente humanos.

Similar Documents

Publication Publication Date Title
JP2021523702A5 (https=)
JP2024056895A5 (https=)
JP2022068181A5 (https=)
JP2022529631A5 (https=)
JP2021118724A5 (https=)
EP2660325A3 (en) AAV vectors and corresponding nucleotide sequences and methods
JP2022190081A5 (https=)
JP2021514659A5 (https=)
JP2021106619A5 (https=)
JP2018510648A5 (https=)
JP2021512649A5 (https=)
JP2018522529A5 (https=)
JP2022549140A5 (https=)
JP2020519284A5 (https=)
JP2020505936A5 (https=)
JP2020522269A5 (https=)
JP2022508182A5 (https=)
JP2017509632A5 (https=)
JP2022529424A5 (https=)
JP2022551744A5 (https=)
IL292264B1 (en) Aav transfer cassette
JP2019503649A5 (https=)
AU2019250249A1 (en) Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases
JP2023515692A5 (https=)
JP2017535266A5 (https=)